Active

ERUDITE PHARMA

Switched

BE0740537194

Rechtspersoon Private limited company 1 establishment

Burgemeester Gillonlaan(Kor) 81, 8500 Kortrijk Detailhandel in farmaceutische producten

Active for

6 year, 8 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ 194,964

▲ 1% vs 2024

Profit

Caution

€ -17,585

▼ 182% vs 2024

Debts

Normal

€ 1.1 million

▼ 4% vs 2024

ERUDITE PHARMA from Kortrijk, company number BE0740537194, closed financial year 2025 with a result of € -17,585 after tax. For that financial year ERUDITE PHARMA recorded a gross margin of € 194,964 and equity of € 340,033. Compared with financial year 2024, the result moved from € -6,227 to € -17,585. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What happened at ERUDITE PHARMA?

What happened at ERUDITE PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 17,585. Source: NBB ↗
  • New establishment in Kortrijk. KBO
  • Start of the company according to the CBE. KBO

In short

From € 206,806 loss in 2021 to € 17,585 loss in 2025.

On average € 121,900 of value added per employee in 2025.

A new publication or filing at ERUDITE PHARMA? We notify you, reason included.

Follow ERUDITE PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Charles Declerck
Louis Declerck
Augustin Declerck
ERUDITE PHARMA
+5

Behind ERUDITE PHARMA are LISCICOM BVBA, Charles Declerck, Louis Declerck and Augustin Declerck. The same people are also behind Medeca, Trenker HoldCo, T.DIFFUSION, NUTRIPHYT and TRENKER NUTRITION.

See the full network in the app

Directors

According to the 2025 annual accounts

LISCICOM BVBA

Director · represented by Ineke Demuylder

Charles Declerck

Director

Also active at: Medeca, Trenker HoldCo

Louis Declerck

Director

Also active at: T.DIFFUSION, NUTRIPHYT, TRENKER NUTRITION +4 more

Augustin Declerck

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Burgemeester Gillonlaan(Kor) 81

8500 Kortrijk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0740.537.194
VAT number
BE 0740.537.194
Registered office
Burgemeester Gillonlaan(Kor) 81, 8500 Kortrijk
Names & denominations
ERUDITE PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
27 December 2019
Peppol
Active · Active since 28 May 2025
Activities · NACE

Detailhandel in farmaceutische producten

Frequently asked questions

What is the enterprise number of ERUDITE PHARMA?
The enterprise number of ERUDITE PHARMA is BE0740537194.
What is the address of ERUDITE PHARMA?
The registered office of ERUDITE PHARMA is located at Burgemeester Gillonlaan(Kor) 81, 8500 Kortrijk.
When was ERUDITE PHARMA founded?
ERUDITE PHARMA was founded on 27 December 2019.
What is the main activity of ERUDITE PHARMA?
The main activity of ERUDITE PHARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does ERUDITE PHARMA have a website?
No website is currently known for ERUDITE PHARMA.
How much profit did ERUDITE PHARMA make in 2025?
ERUDITE PHARMA recorded a loss after taxes of € 17,585 in financial year 2025.
What is the revenue of ERUDITE PHARMA?
As a small company, ERUDITE PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 194,964.
How many employees does ERUDITE PHARMA have?
According to the 2025 annual accounts, ERUDITE PHARMA has 1.6 full-time equivalents (FTE).
Where can I find the annual accounts of ERUDITE PHARMA?
ERUDITE PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of ERUDITE PHARMA?
According to the 2025 annual accounts, the directors of ERUDITE PHARMA are: LISCICOM BVBA, Charles Declerck, Louis Declerck, Augustin Declerck.
Who owns ERUDITE PHARMA?
Behind ERUDITE PHARMA are LISCICOM BVBA, Charles Declerck, Louis Declerck and Augustin Declerck. The same people are also behind Medeca, Trenker HoldCo, T.DIFFUSION, NUTRIPHYT and TRENKER NUTRITION.